Health Affairs, 27, no. 4 (2008): 1028 doi: 10.1377/hlthaff.27.4.1028 © 2008 by Project HOPE	New Online   Rating Health IT Progress   Consumers And Health IT   Dutch Health System   HIV/AIDS In India, China

This Article Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions PubMed PubMed Citation Related Collections Health Reform International Issues Pharmaceuticals Research And Technology

Biotech & Drugs

PROLOGUE

Biotechnology And Drugs

The rise of global trade presents new opportunities and pitfalls for many once-poor nations largely denied economic prosperity in the past. They now compete for overseas markets in industrialized countries—and consumers in those countries benefit from lower prices. But globalization typically has a darker side as well. Both sides of the story are evident in the pharmaceutical industries of China and India.

For years these countries have been leaders in the low-cost production of both active pharmaceutical ingredients and the fillers that go into medicines. In China, there are now more than 5,000 companies manufacturing low-cost drugs for domestic and . . . [Full Text of this Article]

                      What's this?